These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36415369)

  • 1. A Novel Mutation in the NAGLU (N-Acetyl-Alpha-Glucosaminidase) Gene Associated With Mucopolysaccharidosis Type III-B in a Saudi Girl.
    Albar RF; AlQurashi RA; Naaman N; Alghamdi A; Alghamdi SK; Aljohani K; Alsharif R
    Cureus; 2022 Oct; 14(10):e30519. PubMed ID: 36415369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model of mucopolysaccharidosis IIIB (Sanfilippo syndrome type IIIB): N-acetyl-alpha-D-glucosaminidase deficiency in Schipperke dogs.
    Ellinwood NM; Wang P; Skeen T; Sharp NJ; Cesta M; Decker S; Edwards NJ; Bublot I; Thompson JN; Bush W; Hardam E; Haskins ME; Giger U
    J Inherit Metab Dis; 2003; 26(5):489-504. PubMed ID: 14518829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mutation in the NAGLU gene associated with Sanfilippo syndrome type B (mucopolysaccharidosis III B).
    Hettiarachchi D; Nethikumara N; Pathirana BAPS; Weththasigha K; Dissanayake WDN; Dissanayake VHW
    Clin Case Rep; 2018 Jun; 6(6):1051-1054. PubMed ID: 29881562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Postnatal and prenatal diagnosis of mucopolysaccharidosis type III (Sanfilippo syndrome)].
    Zhang WM; Shi HP; Meng Y; Li BT; Qiu ZQ; Liu JT
    Zhonghua Er Ke Za Zhi; 2008 Jun; 46(6):407-10. PubMed ID: 19099774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sanfilippo syndrome type B: Analysis of patients diagnosed by the MPS Brazil Network.
    Montenegro YHA; de Souza CFM; Kubaski F; Trapp FB; Burin MG; Michelin-Tirelli K; Leistner-Segal S; Facchin ACB; Medeiros FS; Giugliani L; Ribeiro EM; Lourenço CM; Cardoso-Dos-Santos AC; Ribeiro MG; Kim CA; Castro MAA; Embiruçu EK; Steiner CE; Moreira MLC; Montano HQ; Baldo G; Giugliani R
    Am J Med Genet A; 2022 Mar; 188(3):760-767. PubMed ID: 34806811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing of mutant N-acetyl-α-glucosaminidase in mucopolysaccharidosis type IIIB fibroblasts cultured at low temperature.
    Meijer OLM; Te Brinke H; Ofman R; IJlst L; Wijburg FA; van Vlies N
    Mol Genet Metab; 2017 Sep; 122(1-2):100-106. PubMed ID: 28751108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Untypically mild phenotype of a patient suffering from Sanfilippo syndrome B with the c.638C>T/c.889C>T (p.Pro213Leu/p.Arg297Ter) mutations in the NAGLU gene.
    Pierzynowska K; Mański A; Limanówka M; Wierzba J; Gaffke L; Anikiej P; Węgrzyn G
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1356. PubMed ID: 32578945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sanfilippo type B syndrome: five patients with an R565P homozygous mutation in the alpha-N-acetylglucosaminidase gene from the Okinawa islands in Japan.
    Chinen Y; Tohma T; Izumikawa Y; Uehara H; Ohta T
    J Hum Genet; 2005; 50(7):357-359. PubMed ID: 15933803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of 12 novel mutations in the alpha-N-acetylglucosaminidase gene in 14 patients with Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB).
    Beesley CE; Young EP; Vellodi A; Winchester BG
    J Med Genet; 1998 Nov; 35(11):910-4. PubMed ID: 9832037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of mucopolysaccharidosis type IIIB in emu (Dromaius novaehollandiae): an avian model of Sanfilippo syndrome type B.
    Aronovich EL; Johnston JM; Wang P; Giger U; Whitley CB
    Genomics; 2001 Jun; 74(3):299-305. PubMed ID: 11414757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Pathogenic Variant in NAGLU (N-Acetyl-Alpha-Glucosaminidase) gene Identified by Targeted Next-Generation Sequencing Followed by in Silico Analysis.
    Khorrami M; Mahdavi M; Fakhr F; Kheirollahi M
    Iran J Child Neurol; 2019; 13(4):173-183. PubMed ID: 31645877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of mucopolysaccharidosis type IIIB.
    Chuang SC; Hwu WL; Wu CC; Hou JW; Wang TR
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(5):320-3. PubMed ID: 8942024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural characterization of the α-N-acetylglucosaminidase, a key enzyme in the pathogenesis of Sanfilippo syndrome B.
    Birrane G; Dassier AL; Romashko A; Lundberg D; Holmes K; Cottle T; Norton AW; Zhang B; Concino MF; Meiyappan M
    J Struct Biol; 2019 Mar; 205(3):65-71. PubMed ID: 30802506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of a novel homozygous deletion in the alpha-N-acetylglucosaminidase gene in a patient with Sanfilippo type B syndrome (mucopolysaccharidosis IIIB).
    Champion KJ; Basehore MJ; Wood T; Destrée A; Vannuffel P; Maystadt I
    Mol Genet Metab; 2010 May; 100(1):51-6. PubMed ID: 20138557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular defects in Sanfilippo syndrome type B (mucopolysaccharidosis IIIB).
    Beesley CE; Jackson M; Young EP; Vellodi A; Winchester BG
    J Inherit Metab Dis; 2005; 28(5):759-67. PubMed ID: 16151907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tralesinidase Alfa Enzyme Replacement Therapy Prevents Disease Manifestations in a Canine Model of Mucopolysaccharidosis Type IIIB.
    Ellinwood NM; Valentine BN; Hess AS; Jens JK; Snella EM; Jamil M; Hostetter SJ; Jeffery ND; Smith JD; Millman ST; Parsons RL; Butt MT; Chandra S; Egeland MT; Assis AB; Nelvagal HR; Cooper JD; Nestrasil I; Mueller BA; Labounek R; Paulson A; Prill H; Liu XY; Zhou H; Lawrence R; Crawford BE; Grover A; Cherala G; Melton AC; Cherukuri A; Vuillemenot BR; Wait JCM; O'Neill CA; Pinkstaff J; Kovalchin J; Zanelli E; McCullagh E
    J Pharmacol Exp Ther; 2022 Sep; 382(3):277-286. PubMed ID: 35717448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Uptake of NAGLU-IGF2 and Unmodified NAGLU in Cellular Models of Sanfilippo Syndrome Type B.
    Prill H; Luu A; Yip B; Holtzinger J; Lo MJ; Christianson TM; Yogalingam G; Aoyagi-Scharber M; LeBowitz JH; Crawford BE; Lawrence R
    Mol Ther Methods Clin Dev; 2019 Sep; 14():56-63. PubMed ID: 31309128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical diagnosis of Sanfilippo disorder types A and B.
    Nosier SS; El Nakeeb SMS; Ibrahim MM; El-Gammal M; Fateen EM
    J Genet Eng Biotechnol; 2023 Nov; 21(1):112. PubMed ID: 37947910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Throughput Screen Fails to Identify Compounds That Enhance Residual Enzyme Activity of Mutant N-Acetyl-α-Glucosaminidase in Mucopolysaccharidosis Type IIIB.
    Meijer OLM; van den Biggelaar P; Ofman R; Wijburg FA; van Vlies N
    JIMD Rep; 2018; 39():97-106. PubMed ID: 28836185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.